Having validated our experimental approach, we next performed immunostaining and confocal imaging to evaluate the role of CHMP2B in CHMP7 mediated NPC injury, namely the reduction of nuclear POM121 immunoreactivity. This evidence concerns the gene CHMP7 and nasopharyngeal carcinoma.